Since STAT5A expression was negatively correlated with ovarian cancer cell invasion and DNA repair, STAT5A/P-STAT5A activators or inducers may increase ovarian cancer survivorship and allow more of them to benefit from radiotherapy and chemotherapy, molecular targeted drug therapy, or immunotherapy. The gene discussed is STAT5A; the disease is ovarian carcinoma.